Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

ClinicalTrials.gov ID: NCT06272487

Public ClinicalTrials.gov record NCT06272487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and hypertension not adequately controlled by standard of care antihypertensive medications.

Study identification

NCT ID
NCT06272487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alnylam Pharmaceuticals
Industry
Enrollment
375 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2024 (Actual)
Primary completion
Jun 19, 2025 (Actual)
Completion
Dec 1, 2025 (Actual)
Last update posted
Mar 2, 2026

2024 – 2025

United States locations

U.S. sites
139
U.S. states
38
U.S. cities
118
Facility City State ZIP Site status
Clinical Trial Site Alexander City Alabama 35010 —
Clinical Trial Site Daphne Alabama 36526 —
Clinical Trial Site Foley Alabama 36535 —
Clinical Trial Site Huntsville Alabama 35801 —
Clinical Trial Site Huntsville Alabama 35805 —
Clinical Trial Site Montgomery Alabama 36117 —
Clinical Trial Site Gilbert Arizona 85297 —
Clinical Trial Site Phoenix Arizona 85028 —
Clinical Trial Site Sun City Arizona 85351 —
Clinical Trial Site Tempe Arizona 85281 —
Clinical Trial Site Tucson Arizona 85741 —
Clinical Trial Site Beverly Hills California 90211 —
Clinical Trial Site Covina California 91723 —
Clinical Trial Site Encinitas California 92024 —
Clinical Trial Site Garden Grove California 92844 —
Clinical Trial Site Huntington Beach California 92647 —
Clinical Trial Site Los Angeles California 90022 —
Clinical Trial Site Los Angeles California 90057 —
Clinical Trial Site Northridge California 91324 —
Clinical Trial Site Northridge California 91325 —
Clinical Trial Site Pasadena California 91105 —
Clinical Trial Site San Diego California 92108 —
Clinical Trial Site San Diego California 92111 —
Clinical Trial Site San Dimas California 91773 —
Clinical Trial Site Simi Valley California 93065 —
Clinical Trial Site Vacaville California 95687 —
Clinical Trial Site Van Nuys California 91405 —
Clinical Trial Site West Hills California 91307 —
Clinical Trial Site Colorado Springs Colorado 80918 —
Clinical Trial Site Denver Colorado 80210 —
Clinical Trial Site Denver Colorado 80230 —
Clinical Trial Site Hartford Connecticut 06112 —
Clinical Trial Site Middlebury Connecticut 06762 —
Clinical Trial Site Waterbury Connecticut 06708 —
Clinical Trial Site Washington D.C. District of Columbia 20009 —
Clinical Trial Site Clearwater Florida 33756 —
Clinical Trial Site Coral Gables Florida 33134 —
Clinical Trial Site Daytona Beach Florida 32117 —
Clinical Trial Site Fort Myers Florida 33912 —
Clinical Trial Site Hollywood Florida 33021 —
Clinical Trial Site Jacksonville Florida 32204 —
Clinical Trial Site Jacksonville Florida 32209 —
Clinical Trial Site Jacksonville Florida 32256 —
Clinical Trial Site Jensen Beach Florida 34957 —
Clinical Trial Site Lake City Florida 32055 —
Clinical Trial Site Miami Florida 33126 —
Clinical Trial Site Miami Florida 33135 —
Clinical Trial Site Miami Florida 33137 —
Clinical Trial Site Miami Florida 33144 —
Clinical Trial Site Miami Florida 33155 —
Clinical Trial Site Miami Florida 33176 —
Clinical Trial Site Miramar Florida 33027 —
Clinical Trial Site Orlando Florida 32801 —
Clinical Trial Site The Villages Florida 32162 —
Clinical Trial Site Winter Haven Florida 33880 —
Clinical Trial Site Acworth Georgia 30101 —
Clinical Trial Site Atlanta Georgia 30322 —
Clinical Trial Site Columbus Georgia 31904 —
Clinical Trial Site Douglasville Georgia 30134 —
Clinical Trial Site Gainesville Georgia 30501 —
Clinical Trial Site Savannah Georgia 31406 —
Clinical Trial Site Thomasville Georgia 31792 —
Clinical Trial Site Boise Idaho 83706 —
Clinical Trial Site Chicago Illinois 60602 —
Clinical Trial Site Elkhart Indiana 46514 —
Clinical Trial Site Evansville Indiana 47714 —
Clinical Trial Site Richmond Indiana 47374 —
Clinical Trial Site El Dorado Kansas 67042 —
Clinical Trial Site Newton Kansas 67114 —
Clinical Trial Site Wichita Kansas 67207 —
Clinical Trial Site Owensboro Kentucky 42303 —
Clinical Trial Site Monroe Louisiana 71201 —
Clinical Trial Site New Orleans Louisiana 70119 —
Clinical Trial Site Boston Massachusetts 02114 —
Clinical Trial Site West Springfield Massachusetts 01089 —
Clinical Trial Site Flint Michigan 48504 —
Clinical Trial Site Shelby Michigan 48315 —
Clinical Trial Site Ypsilanti Michigan 48197 —
Clinical Trial Site Minneapolis Minnesota 55404 —
Clinical Trial Site Richfield Minnesota 55423 —
Clinical Trial Site Columbus Mississippi 39705 —
Clinical Trial Site Tupelo Mississippi 38801 —
Clinical Trial Site Creve Coeur Missouri 63141 —
Clinical Trial Site Kalispell Montana 59901 —
Clinical Trial Site Lincoln Nebraska 68510 —
Clinical Trial Site Omaha Nebraska 68114 —
Clinical Trial Site Las Vegas Nevada 89121 —
Clinical Trial Site Portsmouth New Hampshire 03801 —
Clinical Trial Site Berlin New Jersey 08009 —
Clinical Trial Site Albuquerque New Mexico 87109 —
Clinical Trial Site New York New York 10017 —
Clinical Trial Site Charlotte North Carolina 28287 —
Clinical Trial Site Durham North Carolina 27704 —
Clinical Trial Site Durham North Carolina 27713 —
Clinical Trial Site Greensboro North Carolina 27401 —
Clinical Trial Site Greenville North Carolina 27834 —
Clinical Trial Site Monroe North Carolina 28112 —
Clinical Trial Site Raleigh North Carolina 27609 —
Clinical Trial Site Wilmington North Carolina 28403 —
Clinical Trial Site Winston-Salem North Carolina 27103 —
Clinical Trial Site Cleveland Ohio 44106 —
Clinical Trial Site Marion Ohio 43302 —
Clinical Trial Site Norman Oklahoma 73072 —
Clinical Trial Site Oklahoma City Oklahoma 73102 —
Clinical Trial Site Bethlehem Pennsylvania 18017 —
Clinical Trial Site Langhorne Pennsylvania 19047 —
Clinical Trial Site Newport Pennsylvania 17074 —
Clinical Trial Site Philadelphia Pennsylvania 19114 —
Clinical Trial Site East Providence Rhode Island 02914 —
Clinical Trial Site Myrtle Beach South Carolina 29572 —
Clinical Trial Site Rapid City South Dakota 57701 —
Clinical Trial Site Chattanooga Tennessee 37404 —
Clinical Trial Site Germantown Tennessee 38138 —
Clinical Trial Site Knoxville Tennessee 37909 —
Clinical Trial Site Knoxville Tennessee 37923 —
Clinical Trial Site Memphis Tennessee 38119 —
Clinical Trial Site Austin Texas 78744 —
Clinical Trial Site Coppell Texas 75019 —
Clinical Trial Site Dallas Texas 75230 —
Clinical Trial Site Dallas Texas 75234 —
Clinical Trial Site El Paso Texas 79925 —
Clinical Trial Site El Paso Texas 79935 —
Clinical Trial Site Houston Texas 77002 —
Clinical Trial Site Houston Texas 77024 —
Clinical Trial Site Houston Texas 77054 —
Clinical Trial Site Houston Texas 77081 —
Clinical Trial Site Houston Texas 77099 —
Clinical Trial Site Magnolia Texas 77355 —
Clinical Trial Site San Antonio Texas 78229 —
Clinical Trial Site San Antonio Texas 78240 —
Clinical Trial Site Shenandoah Texas 77384 —
Clinical Trial Site Sherman Texas 75092 —
Clinical Trial Site Stephenville Texas 76401 —
Clinical Trial Site Tomball Texas 77375 —
Clinical Trial Site Burlington Vermont 05401 —
Clinical Trial Site Burke Virginia 22015 —
Clinical Trial Site Manassas Virginia 20109 —
Clinical Trial Site Norfolk Virginia 23504 —
Clinical Trial Site West Allis Wisconsin 53227 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06272487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06272487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →